Trypanosomiasis – Global Clinical Trial Pipeline Highlights, 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Trypanosomiasis
– Global Clinical Trial Pipeline Highlights, 2019” report has
been added to ResearchAndMarkets.com’s offering.

This report provides most up-to-date information on key pipeline
products in the global Trypanosomiasis market. It covers emerging
therapies for Trypanosomiasis in active clinical development stages
including early and late stage clinical trials.

The pipeline data presented in this report helps executives in tracking
competition, identifying partners, evaluating opportunities, formulating
business development strategies, and executing in-licensing and
out-licensing deals.

Clinical Trial Stages

The report provides Trypanosomiasis pipeline products by clinical trial
stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.

Drug Mechanism Classes

The report provides Trypanosomiasis pipeline products by their dominant
mechanism of action/drug class. This helps executives categorize
products based on their drug class and also assess the strengths and
weaknesses of compounds.

Company

The report provides Trypanosomiasis pipeline products by the company.

Short-term Launch Highlights

Find out which Trypanosomiasis pipeline products will be launched in the
US and Ex-US to 2024.

Key Topics Covered

1. Trypanosomiasis Pipeline by Stages

2. Trypanosomiasis Phase 3 Clinical Trial Insights

3. Trypanosomiasis Phase 2 Clinical Trial Insights

4. Trypanosomiasis Phase 1 Clinical Trial Insights

5. Trypanosomiasis Preclinical Research Insights

6. Trypanosomiasis Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables

Table 1: Trypanosomiasis Phase 3 Clinical Trials, 2019

Table 2: Trypanosomiasis Phase 2 Clinical Trials, 2019

Table 3: Trypanosomiasis Phase 1 Clinical Trials, 2019

Table 4: Trypanosomiasis Preclinical Research, 2019

Table 5: Trypanosomiasis Discovery Stage, 2019

List of Figures

Figure 1: Trypanosomiasis Pipeline Molecules by Clinical Trials Stage,
2019

Figure 2: Trypanosomiasis Phase 3 Clinical Trial Highlights, 2019

Figure 3: Trypanosomiasis Phase 2 Clinical Trial Highlights, 2019

Figure 4: Trypanosomiasis Phase 1 Clinical Trial Highlights, 2019

Figure 5: Trypanosomiasis Preclinical Research Highlights, 2019

Figure 6: Trypanosomiasis Discovery Stage Highlights, 2019

For more information about this report visit https://www.researchandmarkets.com/r/gibn3c

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Diseases Drugs, Clinical
Trials